Vivek Kapur

Associate Director, Huck Institutes of the Life Sciences; Huck Distinguished Chair in Global Health; Professor of Microbiology and Infectious Diseases

Vivek Kapur

Research Summary

The basic mechanisms by which pathogenic microbes successfully infect, colonize, and cause disease in their hosts.

Huck Graduate Students

Huck Affiliations

Links

Publication Tags

These publication tags are generated from the output of this researcher. Click any tag below to view other Huck researchers working on the same topic.

Tuberculosis India Animals Caprine Model Bovine Tuberculosis Escherichia Coli O Antigens Infections Deer Mycobacterium Coronavirus Mycobacterium Tuberculosis Viruses Multigene Family Oral Vaccine Terminology Small Intestine Meta Analysis Infection Proteins Severe Acute Respiratory Syndrome Zoonoses Nutrients Cattle Vaccines

Most Recent Publications

Thomas Holder, Sreenidhi Srinivasan, Adrian McGoldrick, Gareth A. Williams, Simonette Palmer, John Clarke, Amanda O’Brien, Andrew J.K. Conlan, Nick Juleff, H. Martin Vordermeier, Gareth J. Jones, Vivek Kapur, 2024, Scientific Reports

Mohit Kumar, Tarun Kumar, Babu Lal Jangir, Mahavir Singh, Devan Arora, Yogesh Bangar, Andrew Conlan, Martin Vordermeier, Douwe Bakker, S. M. Byregowda, Sreenidhi Srinivasan, Vivek Kapur, Naresh Jindal, 2024, BMC Veterinary Research

Zoonotic tuberculosis in the 21st century

S Duffy, B Marais, Vivek Kapur, M Behr, 2024, The Lancet Infectious Diseases on p. 339-341

Abebe Fromsa, Katriina Willgert, Sreenidhi Srinivasan, Getnet Mekonnen, Wegene Bedada, Balako Gumi, Matios Lakew, Biniam Tadesse, Berecha Bayissa, Asegedech Sirak, Musse Girma Abdela, Solomon Gebre, Tesfaye Chibssa, Maroudam Veerasami, H. Martin Vordermeier, Douwe Bakker, Stefan Berg, Gobena Ameni, Nick Juleff, Mart C.M. de Jong, James Wood, Andrew Conlan, Vivek Kapur, 2024, Science on p. 1433-1441

Rubab Maqsood, Shannon C. Duffy, Hamad Bin Rashid, Shakera Sadiq Gill, Chanda Jabeen, Nimra Arshad, Gulshan Umbreen, Marcel A. Behr, Vivek Kapur, Mamoona Chaudhry, 2024, Microbiology spectrum

Jule Goike, Ching Lin Hsieh, Andrew P. Horton, Elizabeth C. Gardner, Ling Zhou, Foteini Bartzoka, Nianshuang Wang, Kamyab Javanmardi, Andrew Herbert, Shawn Abbassi, Xuping Xie, Hongjie Xia, Pei Yong Shi, Rebecca Renberg, Thomas H. Segall-Shapiro, Cynthia I. Terrace, Wesley Wu, Raghav Shroff, Michelle Byrom, Andrew D. Ellington, Edward M. Marcotte, James M. Musser, Suresh V. Kuchipudi, Vivek Kapur, George Georgiou, Scott C. Weaver, John M. Dye, Daniel R. Boutz, Jason S. McLellan, Jimmy D. Gollihar, 2023, Communications Biology

Simon King, Michael D. Baron, Menbere Kidane, Fasil Aklilu, Vivek Kapur, Catherine M. Herzog, Carrie Batten, 2023, Genome Announcements

Lydia Jennifer Sumanth, Christina Rachel Suresh, Manigandan Venkatesan, Abi Manesh, Marcel A. Behr, Vivek Kapur, Joy Sarojini Michael, 2023, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases

Megha Sharma, Karikalan Mathesh, Premanshu Dandapat, Asok Kumar Mariappan, Ravi Kumar, Soni Kumari, Vivek Kapur, Sushila Maan, Naresh Jindal, Nitish Bansal, Riyaz Kadiwar, Abhishek Kumar, Nitin Gupta, A. M. Pawde, A. K. Sharma, 2023, Emerging Infectious Diseases on p. 661-663

Most-Cited Papers

Suresh V. Kuchipudi, Meera Surendran-Nair, R Ruden, M Yon, R Nissly, Kurt J. Vandegrift, R Nelli, Lingling Li, Bhushan Jayarao, Costas D. Maranas, N Levine, K Willgert, Andrew J.K. Conlan, Conlan AJK, R Olsen, J Davis, J Musser, Peter John Hudson, Vivek Kapur, 2022, Proceedings of the National Academy of Sciences of the United States of America

Eric Salazar, 23 names , Suresh Kuchipudi, Isabella Cattadori, Paul Christensen, Todd Eagar, Xin Yi, Picheng Zhao, Zhicheng Jin, S. Long, Randall Olsen, Jian Chen, Brian Castillo, Christopher Leveque, Dalton Towers, Jason Lavinder, Jimmy Gollihar, Jose Cardona, Gregory Ippolito, Ruth Nissly, Ian Bird, Denver Greenawalt, Randall Rossi, Abhinay Gontu, Sreenidhi Srinivasan, Indira Poojary, I Cattadori, Peter J. Hudson, Nicole Josleyn, Laura Prugar, Kathleen Huie, Andrew Herbert, David Bernard, John Dye, Vivek Kapur, James Musser, 2020, Journal of Clinical Investigation on p. 6728-6738

Chitrita DebRoy, Pina M. Fratamico, Xianghe Yan, Gian Marco Baranzoni, Yanhong Liu, David S. Needleman, Robert Tebbs, Catherine D. O'Connell, Adam Allred, Michelle Swimley, Michael Mwangi, Vivek Kapur, Juan A. Raygoza Garay, Elisabeth L. Roberts, Robab Katani, 2016, PLoS One on p. e0147434

Xiaohui Liu, Yi ling Wang, Jacky Wu, Jianjun Qi, Zihua Zeng, Quanyuan Wan, Zhenghu Chen, Pragya Manandhar, Victoria S. Cavener, Nina R. Boyle, Xinping Fu, Eric Salazar, Suresh V. Kuchipudi, Vivek Kapur, Xiaoliu Zhang, Michihisa Umetani, Mehmet Sen, Richard C. Willson, Shu hsia Chen, Youli Zu, 2021, Angewandte Chemie - International Edition on p. 10273-10278

Cedric C.S. Tan, Su Datt Lam, Damien Richard, Christopher J. Owen, Dorothea Berchtold, Christine Orengo, Meera Surendran Nair, Suresh V. Kuchipudi, Vivek Kapur, Lucy van Dorp, François Balloux, 2022, Nature Communications

Sreenidhi Srinivasan, Laurel Easterling, Bipin Rimal, Xiaoyue Maggie Niu, Andrew J.K. Conlan, Patrick Dudas, Vivek Kapur, 2018, Transboundary and Emerging Diseases on p. 1627-1640

Shannon C. Duffy, Sreenidhi Srinivasan, Megan A. Schilling, Tod Stuber, Sarah N. Danchuk, Joy S. Michael, Manigandan Venkatesan, Nitish Bansal, Sushila Maan, Naresh Jindal, Deepika Chaudhary, Premanshu Dandapat, Robab Katani, Shubhada Chothe, Maroudam Veerasami, Suelee Robbe-Austerman, Nicholas Juleff, Vivek Kapur, Marcel A. Behr, 2020, The Lancet Microbe on p. e66-e73

Murray E. Hines, Sue E. Turnquist, Marcia R.S. Ilha, Sreekumari Rajeev, Arthur L. Jones, Lisa Whittington, John P. Bannantine, Raúl G. Barletta, Yrjö T. Gröhn, Robab Katani, Adel M. Talaat, Lingling Li, Vivek Kapur, 2014, Frontiers in cellular and infection microbiology on p. 26

Isabella M. Cattadori, Aswathy Sebastian, Han Hao, Robab Katani, Istvan Albert, Kirsten E. Eilertson, Vivek Kapur, Ashutosh Pathak, Susan Mitchell, 2016, PLoS One on p. e0159770

Sreenidhi Srinivasan, Gareth Jones, Maroudam Veerasami, Sabine Steinbach, Thomas Holder, Aboma Zewude, Abebe Fromsa, Gobena Ameni, Laurel Easterling, Douwe Bakker, Nicholas Juleff, Glen Gifford, R. G. Hewinson, H. Martin Vordermeier, Vivek Kapur, 2019, Science advances on p. eaax4899

News Articles Featuring Vivek Kapur

Vaccine protects cattle from bovine tuberculosis, may eliminate disease

Bovine tuberculosis (TB) is a livestock disease that results in large economic losses to animal agriculture worldwide. The disease can also transmit to humans and cause severe illness and death.

Metabolomics Core Facility continues to expand while pushing scientific bounds

Established nearly a decade ago, Penn State’s Metabolomics Core Facility is housed in the Huck Institutes of the Life Sciences on the University Park campus.

The Michigan Mink Mystery: How Did an Interspecies Outbreak Unfold?

The puzzling coronavirus cases highlight ongoing surveillance challenges and blind spots.

Preventing, controlling spread of animal diseases focus of forum at Penn State

Exploring the emergence, spread and control of animal infectious diseases was the focus of the inaugural Emerging Animal Infectious Disease Conference held Nov. 29-Dec.1, 2021, at Penn State. It was hosted by the College of Agricultural Sciences, the Pennsylvania Department of Agriculture, and Penn State’s Center for Security Research and Education.

The Coronavirus Menagerie

With the virus widespread in white-tailed deer, scientists wonder which animals might be next.

Omicron detected for first time in white-tailed deer

Some white-tailed deer living in Staten Island, New York, are actively infected with the Omicron (B.1.1.529) variant of SARS-CoV-2, according to new research led by scientists at Penn State. The team also found neutralizing antibodies to SARS-CoV-2 in one of the Omicron-infected deer, suggesting that, like humans, deer can be reinfected with the virus.

COVID-19 May Be Widespread in Deer

An analysis by Penn State and Iowa researchers found that Covid-19 may be fairly widespread among white-tailed deer. Up to 80 percent of the deer sampled in Iowa from April 2020 through January 2021 were infected with COVID-19. And The U.S. Department of Agriculture has confirmed Covid infections in deer in 15 states total.

Omicron-Infected Whitetail Deer Detected in New York

The first cases of whitetail deer carrying the Omicron variant of the COVID-19 virus have been discovered in Staten Island, New York. Researchers there report that 19 of 131 deer sampled between December 12, 2021, and Janauary 31, 2022, tested positive for the virus’ antibodies, indicating prior exposure to the coronavirus. PCR (polymerase chain reaction) nasal swab testing of 68 deer revealed that seven were actively infected, with at least four of those confirmed to be Omicron.

Omicron Has Been Found in Deer—That Should Worry Us

There are more than 30 million white-tailed deer in the U.S. That’s a boon for hunters, a headache for gardeners, a hazard for drivers—and now, it appears, a possible problem in the world’s ongoing effort to control the COVID-19 pandemic.

Omicron found in NYC deer raises questions about COVID transmission from animals to humans

The discovery of deer in New York City infected with the omicron variant is raising questions about whether or not animals could potentially transmit COVID-19 to humans.

Not just humans: Study finds NYC omicron spike hit deer too

When New York City’s COVID-19 rates spiked last December due to the emerging omicron variant, humans weren’t the only mammals affected.

Is the Coronavirus in Your Backyard?

White-tailed deer could become a reservoir for the virus, putting people and animals at risk, health experts say.

Scientists discover shockingly high rates of COVID infections among white-tailed deer

Scientists have recently discovered what they are calling a silent outbreak of coronavirus among white-tailed deer. William Brangham reports about how one of the most ubiquitous species in North America contracted COVID, and what that means for the future of the pandemic.

How SARS-CoV-2 in American deer could alter the course of the global pandemic

Scientists have evidence that SARS-CoV-2 spreads explosively in white-tailed deer and that the virus is widespread in this deer population across the United States.

Uh Oh, the Coronavirus Has Been Spreading Widely in U.S. Deer

Up to a third of deer in Iowa had recently been infected by SARS-CoV-2, according to one estimate.

Deer in Iowa appear to be catching COVID-19 from humans. Could it happen in other states?

The coronavirus appears to have infected many of Iowa’s deer, posing risks the virus could mutate in the animals and then re-enter the human population in an altered version, a new study says.

Wild deer are giving each other COVID—a lot

Animals hosting the virus may act as a reservoir.

Scientists fear animals could harbor coronavirus and then pass it back to humans

“This also raises the possibility of the spillback from deer back to humans, especially in exurban areas with high deer densities,” researchers said.

Research Suggests Extensive COVID-19 Infections In White-Tailed Deer

The majority of Iowa's white-tailed deer may already be infected with the coronavirus.

Researchers Detect Coronavirus in Iowa Deer

Multiple white tailed deer tested positive for SARS-CoV-2 likely transmitted from humans, a study finds, indicating the species could act as a reservoir for the virus.

Deer may be reservoir for SARS-CoV-2, study finds

The findings of a study by Penn State and Iowa researchers suggest that white-tailed deer may be a reservoir for the SARS-CoV-2 virus to continually circulate, and raises concerns of emergence of new strains that may prove a threat to wildlife and, possibly, to humans.

Widespread Coronavirus Infection Found in Iowa Deer, New Study Says

The analysis by Penn State and Iowa researchers strongly indicates that deer are getting the virus from humans, worrying experts about a deep wild reservoir for the virus.

Huck Welcomes Sindura Ganapathi as Visiting Fellow in Global Heath

Ganapathi, a Penn State alum who now works for the Indian government, will give a pair of lectures next week while he visits University Park.

Study finds short window for donating convalescent plasma to COVID-19 patients

The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency-use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new Penn State-led study.

Study finds short window for donating convalescent plasma to COVID-19 patients

The optimal timeframe for donating convalescent plasma for use in COVID-19 immunotherapy, which was given emergency use authorization by the Food and Drug Administration in August 2020, is within 60 days of the onset of symptoms, according to a new study. The research also reveals that the ideal convalescent plasma donor is a recovered COVID-19 patient who is older than 30 and whose illness had been severe.